Related Experiment Video
Updated: Jul 6, 2026

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
RanBP2: a tumor suppressor with a new twist on TopoII, SUMO, and centromeres
Michelle S Navarro1, Jeff Bachant
1Department of Cell Biology and Neuroscience, University of California, Riverside, Riverside, CA 92521, USA.
Abstract:
In vertebrate cells, the small ubiquitin-like modifier SUMO plays a poorly defined role in targeting DNA topoisomerase II (TopoII) to centromeres (CENs) during mitosis, presumably to facilitate the untangling of sister chromatids as cells transition into anaphase. A new study by Dawlaty in the April 4 issue of Cell identifies the nucleoporin RanBP2 as a novel tumor suppressor that acts as a SUMO ligase for TopoII. Analysis of this interaction reveals TopoII recruitment to CENs is likely to play an important role in preventing chromosome segregation errors that lead to cancer.
Insights
The nucleoporin RanBP2 acts as a SUMO ligase for DNA topoisomerase II (TopoII), crucial for targeting it to centromeres. This interaction is vital for preventing chromosome segregation errors and may function as a tumor suppressor mechanism.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- The small ubiquitin-like modifier SUMO has an unclear role in directing DNA topoisomerase II (TopoII) to centromeres during mitosis.
- Proper centromere targeting of TopoII is essential for resolving sister chromatid entanglement before anaphase.
Purpose of the Study:
- To identify novel proteins involved in the SUMOylation of TopoII.
- To elucidate the role of RanBP2 in TopoII centromere localization and its implications for chromosome segregation.
Main Methods:
- SUMOylation assays
- Immunofluorescence microscopy
- Analysis of chromosome segregation in cell models.
Main Results:
- The nucleoporin RanBP2 was identified as a SUMO ligase for TopoII.
- RanBP2 facilitates the recruitment of TopoII to centromeres.
- Dysregulation of this interaction is linked to chromosome segregation errors.
Conclusions:
- RanBP2 acts as a tumor suppressor by SUMOylating TopoII and ensuring its proper centromeric localization.
- This mechanism is critical for maintaining genomic stability and preventing cancer development.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Histone Variants at the Centromere
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

